RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Enisamium is an orally available therapeutic that inhibits influenza A virus and SARS-CoV-2 replication.We evaluated the clinical efficacy of enisamium treatment combined Nappy Pants with standard care in adult, hospitalized patients with moderate COVID-19 requiring external oxygen.Hospitalized patients with laboratory-confirmed SARS-CoV-2 infectio